Use of platelet glycoprotein IIb/IIIa inhibitors and spontaneous pulmonary hemorrhage

Journal of Invasive Cardiology

Volumn 15, Issue 4, 2003, Pages 186-188

  Ali, Arshad ^a   Hashem, Mustafa ^a   Rosman, Howard S ^a   Kazmouz, Ghassan ^a   Gardin, Julius M ^a   Schrieber, Theodore L ^a  

^a NONE

Author keywords

Percutaneous coronary intervention; Platelet glycoprotein IIb IIIa inhibitors; Pulmonary hemorrhage

Indexed keywords

ABCIXIMAB; ANTICOAGULANT AGENT; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TIROFIBAN;

ADULT; AGED; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; CORONARY STENT; DISEASE PREDISPOSITION; FEMALE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEMATOLOGICAL PARAMETERS; HEMODYNAMIC PARAMETERS; HEMOPTYSIS; HUMAN; INTERVENTIONAL RADIOLOGY; LUNG CAPILLARY PRESSURE; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANTIBODIES, MONOCLONAL; FEMALE; HEMORRHAGE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INCIDENCE; LUNG DISEASES; MALE; MICHIGAN; MIDDLE AGED; PEPTIDES; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PULMONARY WEDGE PRESSURE; TREATMENT FAILURE; TYROSINE; VENTRICULAR PRESSURE;

EID: 0037390927     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Coller BS, Peerschke EI, Scudder LE, Sullivan CA. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J Clin Invest 1983;72:325-338.
2. Knight DM, Wagner C, Jordan R, et al. The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regions. Mol Immunol 1995;32:1271-1281.
3. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty. N Engl J Med 1994;330:956-961.
4. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995;332:1553-1559.
5. Lefkovits J, Topol EJ. Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery disease. Eur Heart J 1996;17:9-18.
6. The platelet glycoprotein IIb/IIIa in unstable angina. Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes without persistent ST-segment elevation: A randomized, placebo-controlled, clinical trial. N Engl J Med 1998;339:436-443.
7. The ESPRIT Investigators. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): A randomized, placebo-controlled trial. Lancet 2000;356:2037-2044.
8. The PRISM-PLUS Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q wave myocardial infarction. N Engl J Med 1998;338:1488-1497.
9. Albeida SM, Gefter WB, Epstein DM, Miller WT. Diffuse pulmonary hemorrhage: A review and classification. Radiology 1985;289-297.
10. Cohen SA, Effron MB. Correspondence. N Engl J Med 1998;339:1862.
11. Sitges M, Villa FP. Massive pulmonary hemorrhage in a patient treated with a platelet glycoprotein IIb/IIIa inhibitor. Int J Cardiol 1997;62:269-271.
12. Khaniou H, Tsiodras S, Eiger G, et al. Fatal alveolar hemorrhage and abciximab therapy for acute myocardial infarction. Cathet Cardiovasc Diagn 1998;44:313-316.
13. Khaniou H, Eiger G, Yazdanfar H. Correspondence: Abciximab and alveolar hemorrhage. N Engl J Med 1998;339:1861-1862.
14. Ali A, Patil S, Grady KJ, Schreiber TL. Diffuse alveolar hemorrhage following administration of tirofiban or abciximab: A nemesis of platelet glycoprotein IIb/IIIa inhibitors. Cathet Cardiovasc Intervent 2000;49:181-184.
15. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-1696.
16. Kalra S, Bell MR, Rihal CS. Alveolar hemorrhage as a complication of treatment with abciximab. Chest 2001;120:126-131.